Skip to content

Comparative Study Between Three Methods of Stem Cell Separation From Umbilical Cord Blood

A study comparing the effectiveness of the density gradient separation using ficoll hypaque, automated processing and harvesting system using AXP Autoxpress- Thermogenesis and magnetic bead separation system using MACS Columns and MACS Separators methods for stem cell separation from umbilical cord blood

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000058673
Enrollment
30
Registered
2014-01-20
Start date
2014-02-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of the work is to compare three different methods of stem cell separation from umbilical cord blood to define the stem cell separation method with the highest outcome of stem cell count

Interventions

This study will be carried out on 30 samples of umbilical cord blood. Each sample of cord blood will be collected from the placenta using a special collection bag containing anticoagulant (citrate phosphate dextrose adinine). The samples will be divided into three groups: 1. 10 samples of the cord blood from which stem cells will be separated by density gradient separation using ficoll hypaque. This method is performed by centrifugation of a suspension of the cord blood mixed with ficoll-paqu

This study will be carried out on 30 samples of umbilical cord blood. Each sample of cord blood will be collected from the placenta using a special collection bag containing anticoagulant (citrate phosphate dextrose adinine). The samples will be divided into three groups: 1. 10 samples of the cord blood from which stem cells will be separated by density gradient separation using ficoll hypaque. This method is performed by centrifugation of a suspension of the cord blood mixed with ficoll-paque followed by isolation of mononuclear cells. 2. 10 samples of the cord blood from which stem cells will be separated by automated processing and harvesting system using AXP autoexpress - Thermogenesis. Cord blood is transferred into the processing bagset which is placed in the AXP device and then centrifuged. During centrifugation, component stratification and separation occurs. 3. 10 samples of the cord blood from which stem cells will be separated by magnetic bead separation system using MACS Columns and MACS Separators. That depends on labeling CD34+ cells with CD34 microbeads then, the cell suspension is loaded onto a MACS Column which is placed in the magnetic field of a MACS Separator. After removing the column from the magnetic field, the magnetically retained CD34+ cells can be eluted as the positively selected cell fraction.

Sponsors

Faculty of Medicine - Alexandria University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Mothers must have consented for cord blood collection at delivery 2. cord blood must be available for extraction of stem cells. 3. >30 weeks gestation

Exclusion criteria

1. Mothers who would not consent to participate in the study. 2. Chromosomal Abnormalities. 3. Congenital Anomalies.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026